Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE)

被引:1
|
作者
Avery, Leah [1 ,2 ]
Smith, Hollie [1 ]
McPherson, Stuart [2 ,3 ,4 ]
Hallsworth, Kate [2 ,3 ,4 ]
机构
[1] Teesside Univ, Sch Hlth & Life Sci, Middlesbrough, England
[2] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, England
[3] Newcastle Tyne Hosp NHS Fdn Trust, Liver Unit, Newcastle Upon Tyne, England
[4] NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, England
关键词
Non-alcoholic fatty liver disease; NAFLD; Lifestyle behaviour change; Diet; Physical activity; Weight loss; Supported self-management; Digital intervention; Feasibility study; NAFLD; PROGRESSION;
D O I
10.1186/s40814-023-01286-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundNon-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from simple fatty liver to non-alcoholic steatohepatitis, cirrhosis, liver cancer and liver failure. NAFLD affects up to 30-40% of adults in Western countries and is directly linked to overweight and obesity. There are no approved drugs to specifically target NAFLD, therefore weight loss achieved through changes in dietary and physical activity behaviours is the recommended management approach. However, achieving and sustaining weight loss is challenging for patients with NAFLD. We developed a NAFLD-specific digital lifestyle intervention (VITALISE) to target changes in dietary and physical activity behaviours of patients with NAFLD to initiate weight loss and weight loss maintenance. This study aims to evaluate the feasibility and acceptability of VITALISE in a secondary care clinical setting.MethodsA single-centre, one-arm, prospective design will be used to assess the feasibility and acceptability of recruitment, uptake, engagement and completion of VITALISE. Health-related outcomes will be assessed at baseline and 6-months. An interim measure of self-reported weight, physical activity and self-efficacy will be recorded at 12-weeks. Qualitative semi-structured interviews conducted at 6 months follow up will further explore acceptability and feasibility and fidelity of receipt and enactment. The study aims to recruit 35 patients with newly diagnosed NAFLD over a 6-month time period. Eligible patients will have continuous access to VITALISE and monthly tele-coaching support for 6 months prior to follow-up with a hepatologist.DiscussionVITALISE offers access to evidence and theory-informed tailored dietary and physical activity support for patients with NAFLD. The intervention is designed for use by patients in their own time, outside of the hospital setting to overcome well documented challenges including attending additional appointments, and lack of time during routine appointments to adequately address lifestyle behaviour change. This feasibility study will determine the feasibility of VITALISE to support clinical care delivery.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial
    Kyungsun Han
    Ojin Kwon
    Hyo-ju Park
    So-Young Jung
    Changsop Yang
    Chang-Gue Son
    Trials, 21
  • [42] Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial
    Han, Kyungsun
    Kwon, Ojin
    Park, Hyo-Ju
    Jung, So-Young
    Yang, Changsop
    Son, Chang-Gue
    TRIALS, 2020, 21 (01)
  • [43] Liver fat as a dietary target by Chinese Medical Nutrition Therapy (CMNT) diet for treating type 2 diabetes with non-alcoholic fatty liver disease: study protocol for a randomised controlled trial
    Luo, Wu
    Xiao, Zhiyong
    Yang, Xiao
    Wu, Ruiyu
    Li, Jian
    Yu, Zhen
    Guo, Shengxiang
    Nie, Beibei
    Liu, Dongbo
    BMJ OPEN, 2024, 14 (04):
  • [44] Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol
    Gill, Jasleen Kaur
    Pucci, Maria
    Samudio, Ana
    Ahmed, Tibyan
    Siddiqui, Rabail
    Edwards, Nathaniel
    Marticorena, Rosa M.
    Donnelly, Sandra
    Lok, Charmaine
    Wentlandt, Kirsten
    Wolofsky, Kayla
    Mucsi, Istvan
    BMJ OPEN, 2024, 14 (01):
  • [45] Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial
    Dashti, Fatemeh
    Alavian, Seyed Moayed
    Sohrabpour, Amir Ali
    Mousavi, Sara Ebrahimi
    Keshavarz, Seyed-Ali
    Esmaillzadeh, Ahmad
    BMJ OPEN, 2023, 13 (04):
  • [46] Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
    Eriksson, Jan W.
    Lundkvist, Per
    Jansson, Per-Anders
    Johansson, Lars
    Kvarnstrom, Mats
    Moris, Linda
    Miliotis, Tasso
    Forsberg, Gun-Britt
    Riserus, Ulf
    Lind, Lars
    Oscarsson, Jan
    DIABETOLOGIA, 2018, 61 (09) : 1923 - 1934
  • [47] Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
    Jan W. Eriksson
    Per Lundkvist
    Per-Anders Jansson
    Lars Johansson
    Mats Kvarnström
    Linda Moris
    Tasso Miliotis
    Gun-Britt Forsberg
    Ulf Risérus
    Lars Lind
    Jan Oscarsson
    Diabetologia, 2018, 61 : 1923 - 1934
  • [48] Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
    Gracen, Lucy
    Hayward, Kelly L.
    Aikebuse, Melanie
    Russell, Anthony
    O'Beirne, James
    McPhail, Steven
    Irvine, Katharine M.
    Williams, Suzanne
    Valery, Patricia C.
    Powell, Elizabeth E.
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [49] Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
    Lucy Gracen
    Kelly L. Hayward
    Melanie Aikebuse
    Anthony Russell
    James O’Beirne
    Steven McPhail
    Katharine M. Irvine
    Suzanne Williams
    Patricia C. Valery
    Elizabeth E. Powell
    BMC Health Services Research, 22
  • [50] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes
    Sberna, A. L.
    Bouillet, B.
    Rouland, A.
    Brindisi, M. C.
    Nguyen, A.
    Mouillot, T.
    Duvillard, L.
    Denimal, D.
    Loffroy, R.
    Verges, B.
    Hillon, P.
    Petit, J. M.
    DIABETIC MEDICINE, 2018, 35 (03) : 368 - 375